Heart rate recovery is impaired after maximal exercise testing in children with sickle cell anemia.
Anthony M Alvarado, Kendra M Ward, Devin S Muntz...
https://pubmed.ncbi.nlm.nih.gov/25477159/Actively Recruiting
Led by University of California, Irvine · Updated on 2026-10-02
240
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are studying how to measure physical fitness and exercise responses in children and adolescents, especially those with chronic diseases like cystic fibrosis CF, sickle cell disease SCD, and those affected by SARS-CoV-2. This study aims to improve understanding of safe and beneficial physical activity levels for children with these conditions as they move from early to late puberty over 3 to 4 years. It involves collaboration among major NIH clinical research centers to develop new assessment tools that reflect childrens health more accurately. The study uses Cardiopulmonary Exercise Testing CPET with multiple brief exercise bouts on a cycle ergometer to measure cardiorespiratory responses in different groups healthy controls, children with CF, SCD, SARS-CoV-2 history, and hyperlipidemia. Some children may have blood samples taken during exercise to analyze biomarkers and gene expression. The exercise sessions consist of up to eight 2-minute exercise bouts separated by 1-minute rests, performed in a fasted state with an IV placed for blood sampling at specific times. Participants are assessed annually with physical activity measures, gas exchange variables, body composition, biomarkers, gene expression, and behavioral responses to exercise. These evaluations help track the effects of exercise on health as children mature. Safety and fitness are monitored, and outcomes will support the development of improved exercise testing methods. The total study duration spans several years, with assessments focusing on the progression through puberty and the impact of chronic conditions on physical activity.
CONDITIONS
Exercise in Child Health
P
Peter Horvath, Ph.D.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of California, Irvine
Lead Sponsor
Children's Hospital of Orange County
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Sickle Cell Disease Group | Cystic Fibrosis Group | Hyperlipidemia Group | SARS CoV-2 Group | Healthy Control Group |
|---|---|---|---|---|---|
| What it is | Children and adolescents (ages 10-17) with sickle cell disease participating in supervised cardiopulmonary exercise testing including multiple brief bouts for comprehensive physiological assessment. | Children and adolescents (ages 10-17) with cystic fibrosis participating in supervised cardiopulmonary exercise testing using multiple brief exercise bouts to assess cardiorespiratory and metabolic status. | Children and adolescents (ages 10-17) with hyperlipidemia included to explore cardiopulmonary responses during exercise testing. | Children and adolescents (ages 10-17) with a documented history of SARS CoV-2 infection examined for exercise responses through cardiopulmonary testing. | Healthy children and adolescents (ages 10-17), without chronic disease or disability, serve as the control group for comparison during exercise testing. |
| Role in study | Assesses physiological and metabolic response to exercise in participants with sickle cell disease to compare with other pediatric groups. | Evaluates how children with cystic fibrosis perform on exercise testing in relation to their respiratory and metabolic health. | Provides insight into exercise responses among children with hyperlipidemia for comparison with both healthy peers and those with other chronic diseases. | Examines whether previous infection with SARS CoV-2 affects physiological response to exercise in children. | Provides the reference for comparing physiological data against children with chronic disease. |
| Primary use / main goal | To identify differences in exercise tolerance, gas exchange, body composition, and related health markers in youth with sickle cell disease. | Evaluates how exercise affects lung function, gas exchange, and metabolic outcomes in children with cystic fibrosis. | Assesses cardiopulmonary function and metabolic response to exercise among children with hyperlipidemia. | Examines the lasting effects of COVID-19 infection on exercise capacity and physiological responses in pediatric participants. | Provides normative data for all measured physiological markers in this age range. |
| How exercise testing is performed | Under medical supervision, participants with sickle cell disease complete several brief bouts of exercise using a standard cardiopulmonary exercise testing protocol. | Children with cystic fibrosis complete exercise testing with careful monitoring, including gas exchange analysis and metabolic measurements. | Participants with hyperlipidemia perform the same exercise testing protocol used for all disease and control groups. | Participants with past SARS CoV-2 infection undergo exercise testing under staff supervision with health checks before and after activity. | Healthy controls complete the identical supervised exercise testing protocol, establishing a baseline for every measured variable. |
| Evidence status | Prior studies show that children with sickle cell anemia can have reduced fitness and altered cardiovascular responses compared to their healthy peers, but exercise testing provides valuable insights into prognostic and management factors. | Physical activity has been associated with better lung health and improved quality of life in children with cystic fibrosis, according to published studies. | Exercise is widely recommended for management of childhood hyperlipidemia, but specific cardiopulmonary effects in this group are less well characterized. | The long-term effects of SARS CoV-2 infection on exercise responses in children are still being investigated; trial results will add to current understanding. | In healthy children, routine physical activity contributes to cardiovascular and metabolic health, providing a necessary reference for interpreting disease group results. |
| Important limitations | Clinical status (pain crises, anemia, and other complications) may influence the safety and performance of exercise testing in sickle cell disease, and participation is limited to those without recent severe complications. | Children with advanced lung disease or infection may be excluded from exercise testing, limiting generalizability of results to all cases of cystic fibrosis. | The study may not evaluate all subtypes or severities of hyperlipidemia, restricting interpretation of findings to those meeting the trial’s eligibility criteria. | Only includes children with the ability to participate in exercise testing, so results may not generalize to all individuals with post-infectious symptoms or complications. | Control group results reflect healthy children ages 10-17 and may not represent the general population outside this age and health range. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to take part in the study.
1 visit (in-person)
Duration - Annually for 3 to 4 years
Participants perform cardiopulmonary exercise tests involving multiple brief cycling bouts while some may have blood samples taken. Assessments include measurements of heart and lung responses, physical activity, body composition, biomarkers, and gene expression.
Annual visits
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
BASIC_SCIENCE
Number of Arms
5
Have more questions? Get in touch with our team for quick support
Anthony M Alvarado, Kendra M Ward, Devin S Muntz...
https://pubmed.ncbi.nlm.nih.gov/25477159/Christina M Shay, Hongyan Ning, Stephen R Daniels...
https://pubmed.ncbi.nlm.nih.gov/23547177/Ebru Kaya Mutlu, Caner Mutlu, Hanifegul Taskiran...
https://pubmed.ncbi.nlm.nih.gov/26197465/Juan Mielgo-Ayuso, Raquel Aparicio-Ugarriza, Adrián Castillo...
https://pubmed.ncbi.nlm.nih.gov/26914609/Paula Chu, Ankur Pandya, Joshua A Salomon...
https://pubmed.ncbi.nlm.nih.gov/27025969/Diana R R Pacheco, Manuel J B Silva, Ana M S Alexandrino...
https://pubmed.ncbi.nlm.nih.gov/22554022/Katya M Herman, Wilma M Hopman, Catherine M Sabiston
https://pubmed.ncbi.nlm.nih.gov/25660484/Phillip E Gates, W David Strain, Angela C Shore
https://pubmed.ncbi.nlm.nih.gov/19042980/David Jiménez-Pavón, Joanna Kelly, John J Reilly
https://pubmed.ncbi.nlm.nih.gov/19562608/Carol Ann Maher, Monica Toohey, Monika Ferguson
https://pubmed.ncbi.nlm.nih.gov/26218617/University of California, Irvine
Lead Sponsor
Children's Hospital of Orange County
Collaborating Sponsor